Condition: Alzheimer Disease · Sponsor: Heinrich-Heine University, Duesseldorf
This study will primarily investigate the safety and secondarily the effect and applicability of Transcranial Pulse Wave Stimulation (TPS) for the treatment of Alzheimer's disease in the context of a PMCF study (Post-Market Clinical Follow-up). The multicenter, prospective data collection should help to optimize the stimulation protocol, as well as to record frequent to occasional adverse effects of the product and cognitive, affective and subjective scores.
This description comes directly from the study's public registry record.
Lars Wojtecki, Prof. Dr. · +492118106756 · wojtecki@uni-duesseldorf.de
Always discuss trial participation with your own doctor first.
| Ernst von Bergmann Klinikum - Klinik für Neurologie und Klinische Neuropsychologie | Potsdam, Brandenburg, Germany | Recruiting |
| Evangelische Krankenhausstiftung Oldenburg - Universitätsklinik für Neurologie | Oldenburg, Lower Saxony, Germany | Recruiting |
| Universitätsklinikum Bonn - Klinik für Parkinson, Schlaf- und Bewegungsstörungen | Bonn, North Rhine-Westphalia, Germany | Not Yet Recruiting |
| Neurologische Praxis Prof. Wojtecki | Neuss, North Rhine-Westphalia, Germany | Not Yet Recruiting |
| Hospital zum Heiligen Geist GmbH & Co KG Klinik für Neurologie und Neurorehabilitation | Kempen, Germany | Withdrawn |
| Praxis Dr. Schwarz | Ulm, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06313944